Physician profile
Gary S Drizin
NPI 1700848140
$3,406.72
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,155 · 2020: $1,055 · 2021: $44.83 · 2022: $26.17 · 2023: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $125.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $651.35 | 2019-2023 | Nucala |
| Astrazeneca Pharmaceuticals LP | $623.36 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $292.89 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $282.99 | 2019-2021 | |
| Philips North America LLC | $235.97 | 2019-2023 | |
| Mylan Specialty L.P. | $187.93 | 2019-2023 | Yupelri |
| Mallinckrodt Enterprises LLC | $174.92 | 2019 | |
| Jazz Pharmaceuticals INC. | $138.95 | 2019-2020 | |
| Insmed, INC. | $130.33 | 2019-2020 | |
| Genentech USA, INC. | $111.00 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $79.08 | 2020 | |
| Sunovion Pharmaceuticals INC. | $68.11 | 2019-2020 | |
| Circassia INC. | $53.43 | 2019 | |
| Resmed Corp | $49.59 | 2019-2020 | |
| Grifols USA, LLC | $46.58 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $45.32 | 2019-2023 | Tyvaso |
| Actelion Pharmaceuticals US, INC. | $43.40 | 2020-2022 | |
| Genzyme Corporation | $34.36 | 2023 | |
| Harmony Biosciences LLC | $31.74 | 2020-2021 | |
| Pfizer INC. | $31.37 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $24.96 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.68 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $16.19 | 2019 | |
| Electromed, INC. | $14.12 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Drizin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.